Found: 27
Select item for more details and to access through your institution.
Amyloid deposition in primary pulmonary marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
- Published in:
- Pathology International, 2007, v. 57, n. 11, p. 746, doi. 10.1111/j.1440-1827.2007.02164.x
- By:
- Publication type:
- Article
Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI).
- Published in:
- In Vivo, 2023, v. 37, n. 5, p. 2203, doi. 10.21873/invivo.13320
- By:
- Publication type:
- Article
A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101-.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 5, p. 867, doi. 10.1007/s10147-020-01629-6
- By:
- Publication type:
- Article
Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non‐squamous, non‐small cell lung cancer: TORG (thoracic oncology research group) 1321.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 14, p. 14988, doi. 10.1002/cam4.6135
- By:
- Publication type:
- Article
Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 20, p. 6971, doi. 10.1002/cam4.4220
- By:
- Publication type:
- Article
Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 142, doi. 10.1159/000524077
- By:
- Publication type:
- Article
Clinical Impact of Post-Progression Survival on Overall Survival in Elderly Patients with Non-Small-Cell Lung Cancer Harboring Sensitive EGFR Mutations Treated with First-Line EGFR Tyrosine Kinase Inhibitors.
- Published in:
- Chemotherapy (0009-3157), 2018, v. 63, n. 3, p. 181, doi. 10.1159/000490949
- By:
- Publication type:
- Article
Interstitial lung disease associated with trastuzumab monotherapy: A report of 3 cases.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 6, n. 2, p. 229, doi. 10.3892/mco.2016.1113
- By:
- Publication type:
- Article
S-1-containing chemotherapy for patients with non-small-cell lung cancer: A population-based observational study by Ibaraki thoracic integrative (POSITIVE) research group.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 4, n. 6, p. 1025, doi. 10.3892/mco.2016.826
- By:
- Publication type:
- Article
Efficacy of first-line erlotinib in non-small cell lung cancer patients undergoing dose reduction and those with a low body surface area: A population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research Group.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 4, n. 3, p. 425, doi. 10.3892/mco.2015.720
- By:
- Publication type:
- Article
Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research Group.
- Published in:
- Molecular & Clinical Oncology, 2013, v. 1, n. 5, p. 828, doi. 10.3892/mco.2013.154
- By:
- Publication type:
- Article
Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2776, doi. 10.1111/1759-7714.14621
- By:
- Publication type:
- Article
Prognostic value of morphological characteristics assessed by CT scan in patients with non‐small cell lung cancer treated with nivolumab.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3521, doi. 10.1111/1759-7714.13695
- By:
- Publication type:
- Article
Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 10, p. 2867, doi. 10.1111/1759-7714.13622
- By:
- Publication type:
- Article
Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 12, p. 1699, doi. 10.1111/1759-7714.12884
- By:
- Publication type:
- Article
F-18 FDG PET/CT in relapsing polychondritis.
- Published in:
- Annals of Nuclear Medicine, 2010, v. 24, n. 9, p. 687, doi. 10.1007/s12149-010-0406-6
- By:
- Publication type:
- Article
Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
- Published in:
- Annals of Nuclear Medicine, 2009, v. 23, n. 1, p. 49, doi. 10.1007/s12149-008-0205-5
- By:
- Publication type:
- Article
Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR-TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Impact of functional ABCG2 polymorphisms on the adverse effects of gefitinib in Japanese patients with non-small-cell lung cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Impact of functional ABCG2 polymorphisms on the adverse effects of gefitinib in Japanese patients with non–small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 4, p. 691, doi. 10.1007/s00280-009-1211-6
- By:
- Publication type:
- Article
Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.
- Published in:
- Oncology, 2021, v. 99, n. 9, p. 562, doi. 10.1159/000516745
- By:
- Publication type:
- Article
Disseminated cryptococcosis in a geriatric man following high‐dose systemic steroid therapy for severe COVID‐19 pneumonia.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1080729
- By:
- Publication type:
- Article
Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 9, p. 1, doi. 10.3390/medicina57090929
- By:
- Publication type:
- Article
Bevacizumab-containing chemotherapy for non-small cell lung cancer patients: a population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group.
- Published in:
- Medical Oncology, 2012, v. 29, n. 5, p. 3202, doi. 10.1007/s12032-012-0318-5
- By:
- Publication type:
- Article
A population-based study of gefitinib in patients with non-small cell lung cancer.
- Published in:
- Medical Oncology, 2009, v. 26, n. 2, p. 222, doi. 10.1007/s12032-008-9110-y
- By:
- Publication type:
- Article